LEPR and breast cancer: Additionally, the knockdown of LEPR in ER-positive MCF-7 and in triple-negative MDA-MB-231 BC cells (ObR sh) was demonstrated to hamper macrophage recruitment in the tumor microenvironment (TME) and influence immune response.